Purple Biotech (PPBT) Intangibles (2017 - 2026)

Purple Biotech (PPBT) has 10 years of Intangibles data on file, last reported at $7.4 million in Q1 2026.

• Quarterly Intangibles changed N/A year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 million, down 73.57% from the prior year.
• Intangibles was little changed at $7.4 million in Q1 2026 per PPBT's latest filing, from $7.4 million in the prior quarter.
• Across five years, Intangibles topped out at $28.0 million in Q4 2023 and bottomed at $7.4 million in Q4 2025.
• The 5-year median for Intangibles is $20.7 million (2022), against an average of $18.3 million.
• The widest annual swing landed in 2023, when Intangibles surged 35.58%; it then sank 73.57% in 2025.
• Tracing PPBT's Intangibles over 5 years: stood at $20.7 million in 2022, then surged by 35.58% to $28.0 million in 2023, then dropped by 0.72% to $27.8 million in 2024, then slumped by 73.57% to $7.4 million in 2025, then changed by 0.0% to $7.4 million in 2026.
• Per Business Quant, the three latest PPBT Intangibles figures stand at $7.4 million (Q1 2026), $7.4 million (Q4 2025), and $27.8 million (Q4 2024).

Peer Comparison